Involvement of 5-HT3 receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat

British Journal of Pharmacology

Volumn 131, Issue 7, 2000, Pages 1294-1302

  Herges, Sonja ^a   Taylor, David A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cocaine; Fluoxetine; Locomotor activity; Nucleus accumbens; Ondansetron

Indexed keywords

AMOBARBITAL; COCAINE; FLUOXETINE; METHOHEXITAL; ONDANSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; THIOPENTAL; TICARCILLIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; LOCOMOTION; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REARING;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DRUG SYNERGISM; FLUOXETINE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; ONDANSETRON; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0033635028     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703687     Document Type: Article

References (66)

1. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex
2. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata
3. 3 receptor-mediated effect in the raphe nuclei of the rat
4. Further evidence for negative feedback control of serotonin release in the central nervous system
5. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis
6. 3 receptor antagonist
7. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats
8. Serotonin release is modulated by presynaptic autoreceptors
9. 3 Receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats
10. Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: A microdialysis study in freely moving rats
11. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens
12. 3 receptor antagonist GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain
13. Serotoninergic modulation of the dopamine response from the nucleus accumbens
14. The role of serotonin in the actions of psychostimulants: Molecular and pharmacological analyses
15. 1(C) receptors
16. Role of serotonin (2A) and serotonin (2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
17. Microinjection of cocaine into the nucleus accumbens elicits locomotor activity in the rat
18. Serotonin 5-HT(2C) receptors in the shell of the nucleus accumbens modulate cocaine-induced hyperactivity
19. 3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area
20. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT(1A) and 5-HT(1B) receptors with WAY 100,635 and GR 127,935
21. 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine
22. Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices
23. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists
24. 2 antagonist pirenperone
25. Fluoxetine increases the extracellular levels of serotonin m the nucleus accumbens
26. 3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain
27. 3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat
28. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat
29. Modulatory effect of pchlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat
30. Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY100635 into the dorsal and median raphe nuclei of the rat
31. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats
32. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain
33. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study
34. The pharmacology of cocaine related to its abuse
35. AMPA/Kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists
36. 3 Receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum
37. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats
38. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
39. Serotonin 5-HT(2C) receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: A combined dialysis and electrophysiological analysis
40. Mesocorticolimbic dopaminergic network: Functional and regulatory roles
41. Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei
42. Effects of the 5-HT(2C/2B) antagonist SB 206553 on hyperactivity induced by cocaine
43. 4 receptors in the nucleus accumbens shell
44. 3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens
45. 3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells
46. 3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons
47. 3H]-5-HT release from rat frontal cortex slices: The effect of 5-HT agonists and antagonists
48. Ventral tegmental area 5-HT receptors: Mesolimbic dopamine release and behavioural studies
49. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion
50. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis
51. 3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat
52. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens
53. 3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area
54. 3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons
55. 3 receptor antagonists attenuate cocaine-induced locomotion in mice
56. Acute uptake inhibition increases extracellular serotonin in the rat forebrain
57. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex
58. Cocaine: Discussion on the role of dopamine in the biochemical mechanism of action
59. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT(1A) and 5-HT(1B) receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo
60. 3 receptor antagonist, on A9 and A10 dopamine neurons
61. 3 receptors
62. 3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism
63. Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential?
64. 3 receptors
65. 3 receptors